GlassScriptPhysician profile
Jeremy E Schmitz
NPI 1982017927
$3,871.53
in general payments reported to CMS, 2019-2025
25 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what 93% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $231 · 2021: $578 · 2022: $385 · 2023: $165 · 2024: $222 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289 · Travel and Lodging: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.21 |
| Travel and Lodging | $749.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,469.92 | 2023-2025 | Iovera, Zilretta, Exparel |
| Amgen INC. | $1,039.31 | 2019-2025 | Evenity, Prolia |
| Horizon Therapeutics Plc | $385.73 | 2020-2022 | |
| Daiichi Sankyo INC. | $124.99 | 2019 | |
| Lilly USA, LLC | $122.75 | 2019 | |
| Radius Health, INC. | $115.66 | 2021-2025 | Tymlos |
| Novo Nordisk INC | $76.22 | 2019 | |
| Depuy Synthes Sales INC. | $66.67 | 2020-2022 | |
| Titan Surgical Group, LLC | $64.86 | 2024-2025 | |
| Axsome Therapeutics, INC. | $48.93 | 2025 | Symbravo |
| Bioventus LLC | $39.87 | 2025 | Exogen Ultrasound Bone Healing System |
| Avanos Medical | $37.78 | 2022-2025 | Generator |
| Sonex Health, INC. | $34.76 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.83 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $25.53 | 2019 | |
| Abbvie INC. | $24.85 | 2022 | |
| Amarin Pharma, INC. | $22.75 | 2019 | |
| Ani Pharmaceuticals, INC. | $20.04 | 2025 | Purified Cortrophin Gel |
| Kerecis Limited | $18.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pacira Therapeutics, INC. | $15.42 | 2021 | |
| Eisai INC. | $14.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.29 | 2019 | |
| Glaxosmithkline, LLC. | $13.21 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.